Priority Date: 13.03.12 (US 201261610128P)

COMBINATION THERAPY FOR THE TREATMENT OF OVARIAN CANCER

  • Application ID: EP13708435
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
Technology Company
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 13.03.2012 - Priority Date (US 201261610128P)
  • 19.09.2013 - Publication A2 (WO2013135602)
  • 21.01.2015 - Publication A2 (EP2825558)

IPC Classification